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Abstract
In Huntington’s disease (HD), mutant huntingtin (mHtt) disrupts the normal transcriptional program of disease neurons by
altering the function of several gene expression regulators such as Sp1. REST (Repressor Element-1 Silencing Transcription
Factor), a key regulator of neuronal differentiation, is also aberrantly activated in HD by a mechanism that remains unclear.
Here, we show that the level of REST mRNA is increased in HD mice and in NG108 cells differentiated into neuronal-like cells
and expressing a toxic mHtt fragment. Using luciferase reporter gene assay, we delimited the REST promoter regions
essential for mHtt-mediated REST upregulation and found that they contain Sp factor binding sites. We provide evidence
that Sp1 and Sp3 bind REST promoter and interplay to fine-tune REST transcription. In undifferentiated NG108 cells, Sp1 and
Sp3 have antagonistic effect, Sp1 acting as an activator and Sp3 as a repressor. Upon neuronal differentiation, we show that
the amount and ratio of Sp1/Sp3 proteins decline, as does REST expression, and that the transcriptional role of Sp3 shifts
toward a weak activator. Therefore, our results provide new molecular information to the transcriptional regulation of REST
during neuronal differentiation. Importantly, specific knockdown of Sp1 abolishes REST upregulation in NG108 neuronal-like
cells expressing mHtt. Our data together with earlier reports suggest that mHtt triggers a pathogenic cascade involving Sp1
activation, which leads to REST upregulation and repression of neuronal genes.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurode-
generative disorder characterized by involuntary movements,
psychiatric disturbances and cognitive decline. The pathology,
which is characterized by a severe atrophy of the striatum, is due
to an abnormal CAG repeat expansion in exon 1 of the HD gene
that is translated into a polyglutamine (polyQ) expansion at the N-
terminus of huntingtin (Htt) [1]. HD belongs to a group of 10
inherited neurodegenerative disorders, including 7 dominant
spinocerebellar ataxias (SCAs), that are caused by polyQ
expansion in specific disease proteins [2]. It is proposed that
polyQ expansions confer toxic properties to mutant proteins by
causing aberrant protein interactions and aggregation of polyQ-
containing proteolytic fragments [3].
Increasing evidence indicates that mutant Htt (mHtt) disrupts
the normal transcriptional program of disease neurons [4]. Early
studies revealed that the levels of neurotransmitter receptors were
altered in post-mortem brains of early HD [5,6,7,8]. Expression
profiling studies of HD mouse brains showed that hundreds of
genes were deregulated, including a conspicuous decreased
expression of neuronal specific genes in the striatum
[9,10,11,12]. Similarly, microarray analysis of HD post-mortem
brains showed that the most extensive changes occurred in the
striatum where neuronal specific genes expression was reduced
[13]. Altered expression of neuronal specific genes was also
observed in other polyQ disorders. In a SCA1 mouse model,
specific genes involved in glutamate signaling functions were
deregulated in Purkinje cells, one major target of the disease [14].
More strikingly, in a mouse model recapitulating the retinal
degeneration affecting SCA7 patients, the retinopathy correlated
with a global repression of genes specifically involved in
photoreceptor function and morphogenesis, suggesting an alter-
ation of the neuronal differentiation program [15,16].
The mechanisms accounting for neuronal gene repression in
HD are unclear. mHtt was shown to alter the activity of a large
number of regulators of transcription [4,17]. Among these, Sp1 is
one of the most studied. If several lines of evidence suggest that
mHtt binds to Sp1 and causes a loss of Sp1 function on selective
genes promoters [18,19,20], other studies reported that Sp1
protein level is increased in HD and that genetic or pharmaco-
logical approaches which decrease the level or activity of Sp1 have
beneficial effect on HD mice [21,22]. Therefore, the role of Sp1 in
neuronal gene repression is unclear and warrants further
investigation.
The activation of REST (Repressor Element-1 Silencing
Transcription Factor) in HD has gained much attention in
recent years. REST, also named Neuron Restrictive Silencer
PLoS ONE | www.plosone.org 1 December 2010 | Volume 5 | Issue 12 | e14311Factor (NRSF) or Repressor Binding to the X2 box (XBR), is a
critical regulator of neuronal terminal differentiation. REST is
thought to silence neuronal genes in non-neuronal cells. During
neuronal differentiation, REST is progressively downregulated
at the protein level in neural precursors and at the mRNA level
in post-mitotic neurons [23]. In the adult brain, REST
transcript is expressed at very low levels [24]. Importantly,
aberrant expression of REST in differentiating neurons causes
repression of neuronal genes and leads to abnormal neuronal
phenotypes [25,26].
REST binds to repressor element 1 (RE1), which is present at
several hundreds sites in human and mouse genomes, and
many REST regulated genes are essential for neuronal
development and differentiation [27,28]. In cellular and mouse
models of HD, REST shows an increased occupancy on RE1 of
specific gene promoters that correlated with transcriptional
repression of the corresponding neuronal gene products [29].
Consistently, ChIP-on-chip experiments revealed a significant
increased of REST binding on RE1 in postmortem HD brains.
In particular, REST binds to the promoter of brain-derived
neurotrophic factor (BDNF) that is downregulated in HD [30].
A dominant-negative form of REST restored the BDNF level in
HD cells [29].
Zuccato et al [31] showed that Htt interacts with and retains
REST in the cytoplasm of neuronal cells. They proposed that
mHtt causes a loss of Htt retention function in HD, leading to the
nuclear translocation of REST where it represses neuronal genes
[31]. Other studies suggest that REST regulation is altered by
polyQ toxicity. Embryonic-stem cells expressing the Hprt gene
containing a CAG expansion were shown to undergo aberrant
neuronal differentiation correlating with persistent REST expres-
sion [32]. The global level of REST proteins is increased in the
brain of the R6/1 mouse model of HD [33]. Although REST can
regulate its own expression level through a double negative
feedback loop involving REST-dependent expression of a specific
microRNA [34], the mechanism underlying REST upregulation
in HD remains unclear.
Here, we show that REST mRNA is increased in the R6/2
mouse model and NG108 neuronal-like model of HD, and that
REST upregulation occurs at the transcriptional level. Using a
luciferase reporter gene assay, we delimited the REST promoter
regions essential for mHtt-mediated REST upregulation and
found that they contain Sp factor binding sites. Consistently, we
detected by chromatin immunoprecipitation (ChIP) that Sp1 and
Sp3 proteins bind the REST promoter in NG108 cells and R6/2
mouse brains. We provide evidence that Sp1 and Sp3 interplay to
fine-tune REST transcription during neuronal differentiation.
Importantly, we demonstrate that Sp1 contributes to mHtt-
mediated REST upregulation in neuronal-like cells. Thus, our
data reveal an unexpected relationship between two transcrip-
tional regulators, Sp1 and REST, which have both been shown to
contribute to HD pathogenesis.
Materials and Methods
Animal care and use
All experimental procedures for care and use of mice were
performed according to agreements with the Departmental
Direction of Veterinarian Services (Prefecture du Bas-Rhin,
France No. C67-218-5) and IGBMC Animal Welfare Insurance
(NIH, PHS No. A5100-01). Mice were euthanized and brain
tissues were removed for molecular analysis. The HD R6/2 mice
from the Jackson Laboratory (Bar Harbor, ME, USA) were
maintained in a mixed CBAxC57BL6 genetic background [35].
Culturing and differentiation of cell line
The neuroblastoma/glioma NG108-15 rt30 hybrid cell line
were grown in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% foetal calf serum (FCS), 1 g/L D-glucose,
40 mg/ml gentamicin and 0,5 mg/ml G418 [36]. The cells were
maintained in a humidified 5% CO2 atmosphere at 37uC. For
neuronal differentiation, medium was replaced by differentiation
medium composed of DMEM, 1% FCS, 1 g/L D-glucose, 40 mg/
ml gentamicin, 10 mM forskolin and 100 mM IBMX (isobuthyl-
methylxanthine). During time course experiments, the medium
was changed every 2 days.
Plasmid constructs and direct mutagenesis
DNA from human BAC clone RP11-738E22 was used as
template for amplification of the human REST promoter. The
59UTR (23390/+1) and the deletion regions of human REST
promoter were amplified by PCR using specific sets of primers
(supplemental Table S1) with the exception of regions A1 and A2
that were obtained by restriction enzyme digestion of deletion
construct A. PCR fragments were subcloned into the pJET1 vector
(GeneJET
TM PCR cloning kit, Fermentas) then inserted upstream
of the luciferase gene in the pGL3-basic vector using restriction
enzyme digestion.
To create REST promoter regions in which mutations were
introduced in the putative NF-kappa B binding sites, deletion
constructs A, B and C were amplified by PCR using Pfu DNA
polymerase (Agilent Technologies) and sets of primers, which
contained mutated NF-kappa B binding sites (supplemental Table
S2).
Nucleotide sequences of all the clones generated by PCR were
confirmed by sequencing. The Sp1 expression vector, which is a
pN3 vector containing the coding sequence for human Sp1, and
the empty pN3 vector were generous gifts from Guntram Suske
(Marburg, Germany). The pEBGN and pEBGN-Sp1 plasmids
were kindly provided by Dr Gerald Thiel [37]. The expression
vectors of Nter-15Q or Nter-142Q correspond to the pcDNA3.1
vector containing the coding sequence for the first 171 amino acids
of human Htt with 15Q or 142Q, respectively.
siRNA interference
siRNA was transfected into NG108 cells with Lipofectamine
2000 (Invitrogen) in 6-well plates following the manufacturer’s
instructions. For the prolonged knockdown in NG108 cells
differentiated into neuronal-like cells for 6 days, siRNA were
added every 2 days. The control siRNA (OR-003-NEG20) was
purchased from Eurogentec. Mouse Sp1 and Sp3 siRNAs were
purchased from Santa Cruz Biotechnology (sc-29488 for Sp1 and
sc-36544 for Sp3) or Abgene LTD (M-040633-02 for Sp1 and M-
040397-01 for Sp3).
Transient transfection and luciferase reporter assay
Transfections were performed with Lipofectamine 2000 (In-
vitrogen) or FuGENE 6 (Roche) in 6-well plates following the
manufacturer’s instructions. For the experiments done with
NG108 cells differentiated into neuronal-like cells, cells were
transfected 24 h prior to differentiation. For the luciferase
experiments, cells were cotransfected with reporter genes, beta-
galactosidase expression vector as an internal control for
normalization and different expression vectors. The final DNA
concentration in all experiments was maintained constant by
addition of empty expression vector. After 48 h incubation or after
6 days of neuronal differentiation, cells were harvested and assayed
for luciferase and beta-galactosidase activity.
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Cells were lysed in buffer containing 50 mM Tris-HCl pH 7.4,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100, protease and
phosphatase inhibitors. They were incubated for 15 min on ice
and centrifuged at 10 000 rpm for 10 min. Supernatants were
collected and analyzed by SDS-PAGE. Primary antibodies anti-
REST (ab21635, Abcam), anti-Synaptophysin (MAB5258, Che-
micon), anti-Sp1 (sc-14027, Santa Cruz Biotechnology), anti-Sp3
(sc-644, Santa Cruz Biotechnology) and anti-beta-tubulin were
used and revealed with appropriate peroxidase-conjugated
secondary antibodies and ECL chemiluminescent reaction
(Millipore).
RNA extraction and quantitative real-time reverse
transcription-PCR
Total RNA was purified with GenElute
TM Mammalian Total
RNA Miniprep Kit (Sigma-Aldrich) following the manufacturer’s
instructions. Reverse transcription (RT) was performed on 2 mgo f
total RNA using SuperScriptII (Invitrogen) according to the
manufacturer’s instructions. The RT products were used as
template for quantitative real-time PCR using a Light-Cycler
instrument (Roche). The sequences of PCR primers used for gene
expression analysis are indicated in supplemental Table S3. All
results were normalized using quantification of housekeeping
genes (36B4, Hprt or Gapdh) with specific PCR primers.
ChIP assay and quantitative real-time -PCR
Confluent undifferentiated NG108 cells in 10-cm dishes were
treated with formaldehyde at a final concentration of 1% to
cross-link nuclear proteins with genomic DNA. After incubation
for 2 min at 37uC, the reaction was stopped by addition of
glycine (125 mM) for 5 min at room temperature. Cells were
washed twice with cold PBS containing protease and phospha-
tase inhibitors, harvested and centrifuged at 2000 rpm at 4uC
for 4 min. The cellular pellet was lysed in buffer containing
50 mM Tris-HCl pH 8.1, 10 mM EDTA, 1% SDS and
protease inhibitors. After incubation for 30 min on ice, genomic
DNA was fragmented into 200–500 bp fragments by sonication
using the Bioruptor instrument (Diagenode). After sonication,
the sample was diluted in the IP buffer (16,7 mM Tris-HCl
pH 8.1, 167 mM NaCl, 1,1% Triton X-100, 1,2 mM EDTA,
0,01% SDS, protease inhibitors). A fraction of the sample was
conserved as input. The sample was shaken gently at 4uCf o r
2 h with protein A (Protein A Agarose/Salmon Sperm DNA,
16-157C, Upstate). After centrifugation at 1400 rpm at 4uCf o r
1 min, the supernatant was immunoprecipitated overnight at
4uC with the antibodies, anti-Sp1 (sc-14027, Santa Cruz
Biotechnology) or anti-Sp3 (sc-644, Santa Cruz Biotechnology).
Anti-GST antibody was used as a negative control. After
incubating with protein A (Protein A Agarose/Salmon Sperm
DNA, 16-157C, Upstate) at 4uC for 4 h, beads were
sequentially washed with low-salt buffer (0,1% SDS, 1%
TritonX-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1,
150 mM NaCl), high-salt buffer (0,1% SDS, 1% TritonX-100,
2 mM EDTA, 20 mM Tris-HCl pH 8.1, 500 mM NaCl), LiCl
buffer (0,25 M LiCl, 1% Nonidet P-40, 1% sodium deoxycho-
late, 1 mM EDTA, 10 mM Tris-HCl pH 8.1) and twice with
TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). The
immunoprecipitated DNA-protein complex was eluted with
100 mM NaHCO3, 1% SDS. The cross-link was reversed by
incubating at 65uC overnight with 200 mM NaCl. After
incubating with proteinase K for 1 h at 45uC, DNA was
purified and analyzed by quantitative real-time PCR using a
Light-Cycler instrument (Roche). The primers used for ChIP
analysis of mouse REST promoter regions are indicated in
supplemental Table S4.
ChIP experiments using brain samples from R6/2 mice and
wildtype littermates were performed as described in [38]. Briefly,
each immunoprecipitation was performed in triplicates from
whole brains of 3 different mice at 12 week of age. The tissue
was cut into small fragments, fixed by adding 37% formaldehyde
to a final concentration of 1% and incubated for 10 min at room
temperature. Cross-linking was stopped by addition of glycine to
0.125 M. Tissue fragments were washed three times with cold
phosphate-buffered saline and treated with sonication buffer
(50 mM HEPES pH 7.9, 140 mM NaCl, 1 mM EDTA, 1%
Triton X-100, 0.1% sodium dodecyl sulfate, 0.1% Na-deoxycho-
late) containing protease and phosphatase inhibitors. Tissue was
then homogenized, and lysates were sonicated to obtain DNA
fragments of 200 to 500 bp. Samples were centrifuged to pellet
debris and an aliquot was taken for gel analysis and input. The
soluble chromatin fraction was pretreated for 1 h at 4uC with
protein A agarose/Salmon Sperm DNA 250% slurry- (Millipore).
Samples were then incubated overnight at 4uC with anti-Sp1 (sc-
14027, Santa Cruz Biotechnology) or anti-Sp3 (sc-644, Santa Cruz
Biotechnology) antibodies. Protein A agarose/Salmon Sperm
DNA was then added, and the mixture was incubated for 2 h at
4uC. Agarose beads were washed twice for 4 min with sonication
buffer, twice for 4 min with wash buffer A (sonication buffer with
500 mM NaCl), twice for 4 min with wash buffer B (20 mM Tris-
HCl, pH 8.0, 1 mM EDTA, a `.25 M LiCl, a `.5% NP-40, 0.5% Na-
deoxycholate), and finally with Tris-EDTA (TE, pH 8.0). Immune
complexes were eluted from the beads with 1% SDS in TE
(pH 8.0) and protein-DNA cross-links were reversed by adding
200 mM NaCl and heating overnight at 65uC. After treatment
with proteinase K for 2 h at 42uC, the samples were purified by
phenol-chloroform-isoamyl alcohol extraction and precipitated
with ethanol. One-fifteen of the immunoprecipitated DNA and
1% of the input DNA were quantified by real-time quantitative
PCR.
Search for transcription factor binding sites
Alignment of the human, mouse and rat REST gene promoters
was performed using ClustalW and genomic sequences from
GenBank accession numbers AB024498, AB024497 and
NM_031788, respectively. Search for conserved transcription
factor binding sites was performed by combining the PromAn,
TFSearch and MatInspector programs [39,40].
Statistical analysis
All data are expressed as mean 6 SEM, except if stated
otherwise. We performed analysis of significance using a one-way
ANOVA or two-way ANOVA tests followed by Student-New-
man-Keuls Method or a Student’s t test followed by Mann-
Whitney test.
Results
REST expression is increased in Huntington’s Disease
models
Previous studies showed that expression of REST might be
impaired in models of polyglutamine disorders [32,33]. To
thoroughly investigate this possibility and clarify the underlying
mechanism, we analyzed mRNA levels of REST in two different
HD models. First, we found that REST mRNA was significantly
increased in the striatum of 12-week old R6/2 mouse model of
HD compared to wild-type mice (Fig. 1A). Second, we studied the
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neuroblastoma/glioma NG108 hybrid cell line transfected with
mHtt and differentiated into neuronal-like cells by increasing the
intracellular level of cAMP [36]. In untransfected NG108 cells,
mRNA and protein levels of REST decreased with the acquisition
of neuronal differentiation phenotype (Fig. 1B, D), consistent with
the repressive role of REST in neuronal differentiation. Accord-
ingly, decreased REST expression upon neuronal differentiation
was correlated with increased mRNA and protein levels of
Synaptophysin, a neuronal gene silenced by REST [41] (Fig. 1C,
D). Compared to undifferentiated NG108 cells, REST mRNA was
decreased by about 3-fold in 6-day differentiated neuronal-like
cells, while Synaptophysin mRNA was increased up to 5-fold
(Fig. 1B,C).
We then examined the effect of mHtt on REST expression in
NG108 cells expressing an amino-terminal fragment (Nter)
corresponding to the first 171 amino acids of human Htt with
142Q (thereafter called Nter-142Q) or with 15Q as control (Nter-
15Q). mHtt fragment of this size has been shown to cause a
neurological phenotype in mice [42]. After 6 days of neuronal
differentiation, REST mRNA was dramatically increased in Nter-
142Q compared to Nter-15Q expressing cells (Fig. 1E), while the
latter did not differ from cells transfected with an empty expression
vector (data not shown). The expression level of REST in Nter-
142Q neuronal-like cells was comparable to that measured in
undifferentiated NG108 cells (Fig. 1A), suggesting that Nter-142Q
cells undergo aberrant neuronal differentiation. Consistent with
this, the mRNA level of Synaptophysin was significantly decreased
in Nter-142Q compared to Nter-15Q neuronal-like cells (Fig. 1F).
Taken together, these data indicate that the Nter of mHtt induces
aberrant expression of REST.
Mutant huntingtin induces the transcriptional activation
of REST promoter
To clarify the mechanism whereby Nter of mHtt increases the
expression of REST, we characterized the activity of the human
REST promoter using a luciferase reporter gene assay. To do so, we
cloned the 23390/+1 bp fragment of the human REST promoter
upstream of the luciferase gene into the pGL3-basic vector. This
generated the 59UTR-REST vector. The REST promoter
fragment contains three alternative promoters A, B and C, which
drive, respectively, the expression of three upstream exons, a, b
and c (Fig. 2A) [43,44,45]. Each upstream exon can be
alternatively spliced to exon D, which contains the ATG
translation initiation site of REST. In 59UTR-REST vector, exon
D was replaced by the luciferase gene cassette.
Nter-142Q and Nter-15Q cells were transfected with 59UTR-
REST vector and differentiated into neuronal-like cells, prior to
the measurement of luciferase activity. Fig. 2B shows that
luciferase activity was increased up to 2-fold in Nter-142Q
compared to Nter-15Q neuronal-like cells. Thus, the Nter of
mHtt induced the transcriptional activation of the human REST
promoter.
Identification of conserved transcription factor binding
sites in the REST promoter
We reasoned that the transcriptional activation of REST in HD
models might occur indirectly, since mHtt could alter the activity
Figure 1. Increase of REST expression in HD mouse and cellular models. (A) mRNA level of REST in the striatum of 12-week-old wild-type
(open bar) and R6/2 mice (solid bar). mRNA level was determined by quantitative RT-PCR. Each bar represents the mean value 6 sem, *P,0,05 (WT:
n=4; R6/2: n=4). (B,C) mRNA levels of REST (B) and Synaptophysin (C) in NG108 cells during 6 days of neuronal differentiation. mRNA levels were
determined by quantitative RT-PCR. Each bar represents the mean value 6 sem of at least 4 independent experiments performed in triplicates. (D)
Protein levels of REST and Synaptophysin in NG108 cells during 12 days of neuronal differentiation. Protein levels were analyzed by Western blotting
using beta-Tubulin as loading control. (E,F) mRNA levels of REST (E) and Synaptophysin (F) in 6-day differentiated NG108 cells expressing Nter-15Q
(open bar) or Nter-142Q (solid bar). mRNA levels were determined by quantitative RT-PCR. Each bar represents the mean values 6 sem of at least 4
independent experiments performed in triplicate. ***P,0,001.
doi:10.1371/journal.pone.0014311.g001
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REST gene expression. To identify such transcription factor(s), we
performed a sequence alignment of human, mouse and rat REST
promoters to unravel conserved elements. Using bioinformatics
programs (see Materials and Methods), we identified several
putative binding sites conserved between species. Among these, we
found multiple binding sites for AP-1, NF-Kappa B and Sp factors
(Supplemental Fig. S1), whose activities were shown to be altered
in HD [18,19,46,47]. These sites are abundant and dispersed
along the promoter sequence, prompting us to narrow down the
relevant promoter region(s) that mediate the effect of the Nter of
mHtt.
Identification of minimal REST promoter regions
regulated by mutant huntingtin
To identify REST promoter regions that are regulated by the
Nter of mHtt, we performed sequential promoter deletions and
cloned them upstream of the luciferase gene into the pGL3-basic
vector (Fig. 3). Luciferase vectors were cotransfected with Nter-
15Q or Nter-142Q vectors prior to neuronal differentiation of
NG108 cells. When compared to Nter-15Q, Nter-142Q led to an
increase of luciferase activity for all tested promoter regions, with
the exception of region A1. Indeed, we found no significant
difference between the luciferase activities driven by the region A1
in Nter-15Q or Nter-142Q neuronal-like cells (Fig. 3). Interest-
ingly, the region A1 contains one putative AP-1 binding site
(Supplemental Fig. S1), suggesting that AP-1 transcription factors
are not directly involved in REST activation by the Nter of mHtt.
Consistently, the promoter regions A2, A3 and C, lacking AP-1
binding sites (Supplemental Fig. S1), were readily activated by
Nter-142Q (Fig. 3), likely by the activity of transcriptional factors
other than AP-1. Importantly, the results also pointed out three
minimal promoter regions, A3, B3 and C, which were sufficient to
promote activation by Nter-142Q (Fig. 3).
Activation of REST by mutant huntingtin does not
involve NF-Kappa B
Each minimal region, A3, B3 and C, contains putative binding
sites for the transcription factor NF-Kappa B (Supplemental Fig.
S1). NF-Kappa B binding sites are absent of the promoter region
A1, which activity is not increased by Nter-142Q (Supplemental
Fig. S1 and Fig. 3). Therefore, NF-Kappa B represented a good
candidate to mediate the activation of REST by mHtt. Moreover,
several studies have shown that NF-Kappa B activity was impaired
in HD. For instance, mouse and cellular models of HD showed an
increased nuclear translocation of NF-Kappa B correlating with
upregulation of NF-Kappa B target genes [47,48]. To test this
candidate, we generated promoter constructs harbouring muta-
tions within NF-Kappa B binding sites. The core sequence,
GGGRNNYYCC, of each NF-Kappa B binding site was replaced
by the sequence AAARNNYYTT, which is sufficient to abolish
the binding and activity of NF-Kappa B on known NF-Kappa B-
regulated promoters [49,50]. When these constructs were analyzed
for their capacity to drive luciferase expression in Nter-15Q or
Nter-142Q neuronal-like cells, we found that mutations in NF-
Kappa B binding sites did not abolish the activation of REST
promoter by Nter-142Q (Fig. 4). The activity of each alternative
promoter A, B and C, mutated or not in the NF-Kappa B binding
sites, was increased in Nter-142Q compared to Nter-15Q
neuronal-like cells. These results indicate that NF-Kappa B was
not directly involved in the activation of the REST promoter by
the Nter of mHtt in NG108 neuronal-like cells.
Sp1 and Sp3 regulate the REST promoter in
undifferentiated NG108 cells
The three minimal regions, A3, B3 and C, sufficient for REST
activation by Nter of mHtt, are GC-rich (70–80%) and contain
several putative binding sites for the Sp family of transcription
factors. Most of these sites are highly conserved between human,
mouse and rat (Supplemental Fig. S1). GC-rich response elements
in the REST promoter were previously reported, but their exact
roles in REST transcriptional regulation are largely unknown
[44,45,51]. We performed a series of experiments to determine
whether Sp factors could regulate the REST promoter in NG108
cells. We focused on Sp1 and Sp3, whose activities were found to
be altered in HD [18,19,51]. We found that the levels of Sp1 and
Sp3 proteins were high in undifferentiated cells (Fig. 5A and
Supplemental Fig. S2). However, Sp1 and Sp3 levels decreased
upon neuronal differentiation, correlating with the decreased
expression of REST (Fig. 1D). The reduction of Sp1 level was
greater than that of Sp3. Sp1 level decreased by more than 90%
during neuronal differentiation, while the level of Sp3 protein
isoforms were reduced 1,5 to 3 fold (Supplemental Fig. S2). Thus,
the amount and ratio of Sp1/ Sp3 proteins declined along
neuronal differentiation.
We then explored the role of Sp1 in the regulation of the REST
promoter by cotransfecting NG108 cells with the 59UTR-REST
vector and increasing amounts of Sp1 expression vector. As shown
in Fig. 5B, overexpression of Sp1 significantly increased REST
Figure 2. mHtt increases REST expression at the transcriptional
level. (A) Schematic representation of the human REST gene promoter.
Exons a, b and c (open boxes) are downstream of the alternative
promoters A, B and C, respectively. These exons are alternatively spliced
to exon D (solid box) which contains the translation initiation site, with
the adenosine of the ATG start codon being set as +1. A -3390-bp/+1
fragment was cloned upstream of the luciferase reporter gene in the
pGL3-basic vector, to generate the 59UTR-REST vector. (B) Activity of
REST gene promoter in 6-day differentiated NG108 cells expressing
Nter-15Q or Nter-142Q. 59UTR-REST or pGL3-basic vectors were
cotransfected with either Nter-15Q (open bar) or Nter-142Q (solid bar)
and beta-galactosidase expression vectors into NG108 cells. Cells were
harvested after 6 days of neuronal differentiation to measure the
luciferase and beta-galactosidase activities. Luciferase activity was
normalized to beta-galactosidase activity and expressed as fold increase
above the control pGL3-basic. Data are the mean values 6 sem of 3
independent experiments performed in triplicate. ***P,0,001; Nter-15Q
expressing cells vs. Nter-142Q expressing cells.
doi:10.1371/journal.pone.0014311.g002
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human REST promoter. Numbers indicate the relative positions with respect to the ATG start codon. The black lines represent the REST promoter
regions, the open boxes the three exons (a, b, c) and the dotted lines the deletion between promoter regions and the luciferase gene (luc.) (grey box).
On the right, luciferase activities of deletion mutants. Each deletion construct was cotransfected with Nter-15Q (open bar) or Nter-142Q (solid bar)
and beta-galactosidase expression vectors into NG108 cells. Cells were harvested after 6 days of neuronal differentiation to measure luciferase and
beta-galactosidase activities. Luciferase activity was normalized to beta-galactosidase activity and expressed as fold increase above the control pGL3-
basic. Data are the mean values 6 sem of 3 independent experiments performed in triplicate. ***P,0,001; ns: non significant, Nter-15Q-expressing
cells vs. Nter-142Q-expressing cells.
doi:10.1371/journal.pone.0014311.g003
Figure 4. NF-Kappa B is not directly involved in the activation of REST promoter by mHtt. On the left, schematic representations of the
three REST promoters A, B and C, with or without mutation(s) in NF-Kappa B binding sites. Numbers indicate the relative positions with respect to the
ATG start codon. The black lines represent the REST promoter regions, the open boxes the three exons (a, b, c) and the dotted lines the deletion
between promoter regions and the luciferase gene (luc.) (light grey boxes). Dark grey boxes refer to the location of NF-Kappa B binding sites, while X
indicates that these sites were mutated. On the right, luciferase activities of mutated promoters. Each mutated construct was cotransfected with Nter-
15Q (open bar) or Nter-142Q (solid bar) and beta-galactosidase expression vectors into NG108 cells. After 6 days of neuronal differentiation, cells were
harvested to measure the luciferase and beta-galactosidase activities. Luciferase activity was normalized to beta-galactosidase activity and expressed
as fold increase above the activity of construct A, co-expressed with Nter-15Q. Data are the mean values 6 sem of 3 independent experiments
performed in triplicate. ***P,0,001, Nter-15Q-expressing cells vs. Nter-142Q-expressing cells.
doi:10.1371/journal.pone.0014311.g004
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Sp1 is a transcriptional activator of REST promoter in
undifferentiated NG108 cells. To confirm this role, we knocked
down the endogenous Sp1 using a specific siRNA. The specificity
and efficiency of Sp1 siRNA silencing were confirmed by
examining the expression levels of Sp1 and Sp3 by quantitative
RT-PCR and western blot (Supplemental Fig. S3). Consistently,
Sp1 knockdown significantly reduced the mRNA level of REST in
undifferentiated NG108 cells (Fig. 5C). Taken together, these data
show that Sp1 positively regulates the transcriptional expression of
REST in undifferentiated NG108 cells.
To further study the role of Sp transcription factors in the
regulation of REST, we used a more global approach by
expressing a dominant-negative of Sp factors (Sp-DN). Sp-DN is
the DNA binding domain of Sp1, which binds to GC-rich
response elements, and can thus compete with endogenous Sp
factors on promoters [37]. Expression and interfering activity of
Sp-DN in NG108 cells were verified by using the MLN64
promoter, known to be positively regulated by Sp1 [52]
(Supplemental Fig. S4). Surprisingly, when we cotransfected
NG108 cells with 59UTR-REST and Sp-DN vectors, the
overexpression of Sp-DN led to an increased activity of REST
promoter in undifferentiated NG108 cells (Fig. 5D). This result
suggests that Sp-DN prevents the binding of Sp factor having a
repressive effect on REST promoter. Therefore, we hypothesized
that the expression level of REST in undifferentiated NG108 is
controlled by the competition between the activating activity of
Sp1 and the repressive activity of another Sp factor.
Sp3 has a high homology to Sp1, reaching more than 90% in
the DNA-binding domains. Sp3 acts both as activator and
Figure 5. Sp1 and Sp3 regulate REST promoter activity in NG108 cells. (A) Western blot analysis of the level of Sp1 and Sp3 protein in NG108
cells during 12 days of neuronal differentiation. (B) Effect of Sp1 overexpression on REST promoter activity. NG108 cells were cotransfected with
59UTR-REST vector, increasing amount of Sp1 vector (pCMV-Sp1) and control beta-galactosidase expression vector. Cells were harvested 48 h later to
measure luciferase and beta-galactosidase activities. pCMV vector was added to keep the DNA amount constant. Luciferase activity was normalized
to beta-galactosidase and expressed as fold increase above the control vector (open bar). Data are the mean values 6 sem of 3 independent
experiments performed in triplicate. **P,0,01, ***P,0,001, cells transfected with pCMV-Sp1 vs cells transfected with empty pCMV vector alone. (C)
Effect of Sp1 knockdown on REST mRNA expression. NG108 cells were transfected with specific Sp1 siRNA or control siRNA and analyzed 48 h later
for REST mRNA level by quantitative RT-PCR. Each bar represents the mean value 6 sem of at least 4 independent experiments performed in
triplicate. ***P,0,001, Sp1 siRNA vs. control siRNA transfected cells. (D) Effect of a dominant-negative of Sp factors on REST promoter activity. 59UTR-
REST vector was cotransfected with an empty pEBGN vector (open bar) or with dominant-negative Sp1-encoding vector (pEBGN-Sp1) (solid bar) and
beta-galactosidase expression vector into NG108 cells. Cells were harvested 48 h later to measure luciferase and beta-galactosidase activities.
Luciferase activity was normalized to beta-galactosidase and activity of REST promoter without transfection of pEBGN-Sp1 was set to 1. Data are the
mean values 6 sem of 3 independent experiments performed in triplicate. ***P,0,001, pEBGN-Sp1 vs pEBGN transfected cells. (E) Effect of Sp3
knockdown on REST mRNA expression. NG108 cells were transfected with Sp3 siRNA or control siRNA and analyzed 48 h later for REST mRNA level by
quantitative RT-PCR. Each bar represents the mean value 6 sem of at least 4 independent experiments performed in triplicate. ***P,0,001, Sp3 siRNA
vs. control siRNA transfected cells. (F) Sp1 and Sp3 bind REST promoter. ChIP assay was performed to detect Sp1 and Sp3 on REST promoter in NG108
cells using anti-Sp1 and anti-Sp3 antibodies. Sequences covering the regions A, B and C in mouse REST promoter corresponding to the regions A3, B3
and C in human REST promoter were amplified. As a negative control, a sequence 2.0 kb upstream of the region A (N) was amplified. Results are
expressed as fold enrichment compared to value obtained after amplification of region N immunoprecipitated with an anti-GST antibody. Each bar
represents the mean value 6 sem of 6 independent IPs. ***P,0,001.
doi:10.1371/journal.pone.0014311.g005
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showed that Sp3 can repress Sp1-mediated transactivation of
promoters [53,54]. To determine if Sp3 repressed the transcrip-
tional activity of the REST promoter, we knocked down the
endogenous Sp3 using siRNA and analyzed the level of REST
mRNA. The specificity and efficiency of Sp3 siRNA knockdown
were confirmed by examining the expression levels of Sp3 and Sp1
by quantitative RT-PCR and western blot (Supplemental Fig. S3).
Consistent with our hypothesis, Sp3 knockdown led to an
increased level of REST mRNA (Fig. 5E). Taken together, our
data show that both Sp1 and Sp3 regulate REST promoter in
undifferentiated NG108 cells and that Sp1 acts as an activator and
Sp3 as a repressor.
Sp1 and Sp3 directly bind to the REST promoter in
NG108 cells
To assess whether the regulation of REST by Sp1 and Sp3 is
direct or indirect, we performed a ChIP experiment using Sp1 or
Sp3 specific antibodies. Both Sp1 and Sp3 were specifically bound
to the A3 region of the mouse REST promoter in undifferentiated
NG108 cells, but were absent from B3 and C regions, and from a
control genomic DNA fragment located 2,0 kb upstream of the
REST A3 promoter region (Fig. 5F). These results indicate that
Sp1 and Sp3 regulate transcription of Rest gene by acting directly
on its promoter.
REST activation by mutant huntingtin is mediated by Sp1
in NG108 neuronal-like cells
To clarify the role of Sp1 and Sp3 in the transcriptional
activation of REST by Nter of mHtt, we knocked down Sp1 and/
or Sp3 in Nter-15Q and Nter-142Q neuronal-like cells. The
specificity and efficiency of Sp1 siRNA, Sp3 siRNA and Sp1/Sp3
siRNAs silencing in Nter-15Q and Nter-142Q neuronal-like cells
were assessed by western blot and quantitative RT-PCR
(Supplemental Fig. S5). The knockdown of Sp1 in Nter-15Q
neuronal-like cells did not modify the mRNA level of REST
(Fig. 6), suggesting that Sp1 does not regulate the basal activity of
the REST promoter in NG108 neuronal-like cells. However, in
Nter-142Q neuronal-like cells, the inhibition of Sp1 decreased the
Nter-142Q-mediated activation of REST by about 60% (Fig. 6).
This result indicates that REST activation by Nter-142Q in
NG108 neuronal-like cells is mediated by Sp1. The inhibition of
Sp3 significantly decreased REST expression similarly in Nter-
15Q and Nter-142Q neuronal-like cells (Fig. 6), suggesting that
Sp3 is switched from a repressor in undifferentiated NG108 cells
to an activator of REST transcription in NG108 neuronal-like
cells. Moreover, the result indicates that the activating activity of
Sp3 is required for the basal REST expression in neuronal-like
cells.
Consistent with the above results, the double knockdown of Sp1
and Sp3 in neuronal-like cells corroborated their role in REST
expression (Fig. 6). In Nter-15Q neuronal-like cells, Sp1/Sp3
double knockdown reduced REST expression at a level compa-
rable to that of Sp3 knockdown alone (Fig. 6), thereby confirming
that Sp3 is majorly involved in the basal REST expression in these
cells. In Nter-142Q neuronal-like cells, the level of REST
expression was much more reduced by Sp1/Sp3 double
knockdown than by Sp3 or Sp1 knockdown alone (Fig. 6). This
confirms that REST upregulation by Nter-142Q in NG108
neuronal-like cells is predominantly mediated by Sp1, while a
contribution of Sp3 cannot be excluded.
To further investigate the role of Sp1 and Sp3 in mHtt-
mediated upregulation of REST, we performed ChIP experiments
from whole brains of 12 week-old R6/2 mice. As in the striatum,
REST expression was increased in the whole brain of R6/2 mice,
when compared to control mice (Supplemental figure S6).
Although Sp1 and Sp3 signals were not significantly different
between R6/2 and control mice, our data showed that Sp1 and
Sp3 were significantly enriched at the A3 region of REST
promoter in R6/2 brains, but not in control brains (Supplemental
figure S6), indicating that Sp factors might contribute to REST
RNA upregulation in R6/2 mice.
Therefore, our results from NG108 neuronal-like cells indicate
that mHtt-mediated upregulation of REST predominantly
involves Sp1 activity, and possibly Sp3. Our data suggest that
this mechanism also occurs in R6/2 mice.
Discussion
Using cellular and mouse models of HD, we show that REST
mRNA is significantly increased in neurons expressing mHtt
fragments. Our data provide evidence that Sp1 and Sp3
transcription factors regulate REST expression in undifferentiated
NG108 cells and in NG108 cells differentiated into neuronal-like
cells, and that Sp factors transcriptional roles change during the
switch from proliferation to neuronal differentiation. Our study
supports a role for Sp1, and likely Sp3, in the mHtt-mediated
upregulation of REST in NG108 neuronal-like cells and in R6/2
mice, thus suggesting that the effect of mHtt on REST function is
in part indirect.
The mechanism underlying HD pathogenesis is not yet fully
understood. However, numerous studies provide evidence that
part is related to transcriptional dysregulations, which progres-
sively worsen during the course of the disease [4,55,56]. The
activation of REST, a master regulator of neuronal genes [27,28],
has been implicated in this process. Zuccato et al. [30,31] studied
the mechanism of REST activation at the RNA and protein levels.
While no significant increase of REST RNA levels was found in
HD cellular and mouse models, they demonstrated that loss of Htt
function leads to nuclear translocation of REST in various HD
cellular models, thereby causing a REST-mediated repression of
Figure 6. Knockdown of endogenous Sp1 decreases mHtt-
mediated REST activation. NG108 cells were cotransfected with
Nter-15Q or Nter-142Q vectors and Sp1 or/and Sp3 siRNA. After 6 days
of neuronal differentiation, REST mRNA level was analyzed by
quantitative RT-PCR. Each bar represents the mean values 6 sd of at
least 2 independent experiments performed in triplicate. ***P,0,001,
Nter-15Q neuronal-like cells vs. Nter-142Q neuronal-like cells;
###P,0,001, Nter-15Q neuronal-like cells transfected with control
siRNA vs Nter-15Q neuronal-like cells transfected with Sp3 siRNA or Sp1/
Sp3 siRNA.
doi:10.1371/journal.pone.0014311.g006
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Here, we show that the level of REST mRNA is significantly
increased in our HD neuronal-like model as well as in HD R6/2
mice. Our results are consistent with the study of Smith et al. [33]
showing an increased level of REST protein in HD R6/1 mice.
The discrepancy might be due to the use of different methodol-
ogies: Zuccato and collaborators performed a semi-quantitative
method to measure REST RNA level, while we used the accurate
quantitative RT-PCR. Our data are supported by the fact that
Nter-142Q activates the REST promoter in the luciferase gene
reporter assay performed in NG108 neuronal-like cells. Another
explanation for the discrepancy may lie in the HD models per se.
Zuccato et al. [31] mainly studied HD models expressing full
length mHtt, while the HD models analyzed by our group express
Nter fragments of mHtt, suggesting that the full length form and
fragments of mHtt activate REST by different mechanisms.
Packer et al [34] recently showed that MiR-9, a microRNA that
regulates REST expression level, is downregulated in HD and may
account for the observed increase of REST expression. Thus,
mHtt and its Nter fragments could trigger the activation of REST
through 3 different mechanisms: by increasing REST transcrip-
tion, decreasing microRNA regulation and increasing REST
nuclear translocation.
Earlier studies have shown that the REST gene contains 3
alternative promoters, characterized by different levels of activity
[43,44,45]. It was shown that the activities of promoters A and B
were predominant, promoter A being the most active, while the
activity of promoter C was negligible in both proliferating neural
and non-neural cells [44,45]. Our experiments based on the use of
luciferase constructs containing each of the 3 REST promoters
show that the activities of the 3 alternative promoters are increased
by Nter-mHtt in NG108 differentiated into neuronal-like cells
(Fig. 3). The significant activity of promoter C in our experimental
system compared to previous studies might be due to differences in
the reporter constructs. In our study, promoter C (construct C in
Fig. 3) was placed immediately upstream of the luciferase reporter
gene, while constructs used in previous studies had exon C
between the promoter and reporter gene, which is proposed to
contain a repressor region [44].
Bioinformatics analysis revealed that the REST promoters
contained several putative binding sites for AP-1, NF-Kappa B
and Sp factors. Using deletion constructs, we delineated the Nter-
mHtt-responsive minimal regions within each promoter and
excluded a direct implication of the AP-1 element located in
promoter A (Fig. 3). The NF-Kappa B binding elements were
exclusively present within the minimal promoter regions. Howev-
er, mutations of these sites showed that none of the NF-Kappa B
elements were involved in the Nter-mHtt-mediated upregulation
of REST in NG108 neuronal-like cells (Fig. 4).
The Nter-mHtt-responsive minimal regions also contained
several GC-boxes, which are known to be potential Sp binding
elements. Using luciferase reporter and gel-mobility shift assays,
Kojima et al. [45] showed that GC-boxes within promoter A were
functional in the NIH3T3 fibroblasts and the Neuro2a neuroblas-
toma cell line. Since no difference was found between neuronal
and non-neuronal cell types in proliferating conditions, they
suggested that the level of REST gene expression is not
determined by transcription per se in a cell-specific manner. The
authors identified neither the factors that bind these GC-boxes,
nor the mechanism of REST regulation. Our study extends
Kojima’s results by providing several lines of evidence for a specific
role of Sp factors in the regulation of REST in neuronal and non-
neuronal cells. First, using RNAi-based and overexpression
experiments, we demonstrate that Sp factors, Sp1 and Sp3,
regulate REST promoter activity in NG108 undifferentiated and
differentiated into neuronal-like cells (Fig. 5 and 6). Second, our
ChIP data support that promoter A is the main target of Sp
factors, as enrichment of Sp1 and Sp3 is significant at promoter A
in NG108 cells and in R6/2 brains (Fig. 5F and S6). Third, taking
advantage of our cellular system where the activity of REST
promoter was properly compared in a single cell type in
undifferentiated/proliferating versus differentiated/non-proliferat-
ing conditions, we specified the role of Sp1 and Sp3 in the
downregulation of REST expression during neuronal differentia-
tion. Our results provide evidence that Sp1 and Sp3 exert an
antagonistic effect on REST regulation in undifferentiated NG108
cells, Sp1 being an activator and Sp3 an inhibitor (Fig. 5). The
resulting global effect of Sp1 and Sp3 activities ensures high REST
expression in undifferentiated NG108 cells. Moreover, we show
that upon neuronal differentiation, the amount and ratio of Sp1
and Sp3 decrease (as discussed below) and correlate with a
reduction of the basal activity of the REST promoter.
The complex interplay of Sp1 and Sp3 in REST regulation can
be rationally interpreted in the light of earlier studies. Sp3 is
known to be a versatile transcription factor [53,54], which either
suppresses promoter activation by Sp1 or, at the opposite,
cooperates with Sp1 on promoters. The outcome appears to
depend on the cellular and gene promoter context. Our data
suggest that Sp3 behaves as an activator and a repressor on the
REST promoter in NG108 cells, depending of the differentiation
state. The RNAi experiments indeed show that Sp3 behaves as an
activator of REST in neuronal-like cells expressing the Nter of
wildtype Htt (Fig. 6). It is believed that the relative ratios between
Sp factors, post-translational modifications or specific interactions
with other transcription factors modulate the transcriptional
competence of Sp factors at a given promoter in a cell- or
signal-specific manner [53,54]. Our western-blotting and RNAi
experiments show that Sp1 protein was strongly decreased during
neuronal differentiation. Sp3 proteins were also reduced during
neuronal differentiation, but less than Sp1 proteins (Fig. 5A). This
indicates that both the relative ratio and global amounts of Sp1
and Sp3 isoforms change upon neuronal differentiation, which
likely contribute to modify the transcriptional role of Sp3. In
contrast to Sp1, Sp3 lacks the ability to transactivate synergistically
via two or more Sp sites. In consequence, it has been proposed that
if Sp3 replaces Sp1 on promoters containing two of more Sp sites,
the transactivation effect of Sp3 would be weaker than that of Sp1,
resulting in a net repression of the initial Sp1-mediated
transactivation [53]. We suggest that this situation might occur
at the REST promoter upon neuronal differentiation: decrease of
Sp1/Sp3 ratio would contribute to down regulation of REST
during neuronal differentiation by reducing the basal activity of
the promoter. This mechanism provides for the first time a
molecular clue to the transcriptional repression of REST upon
neuronal differentiation.
Our ChIP and RNAi-based results support a role for Sp1, and
probably Sp3, in the mHtt-mediated upregulation of REST in
NG108 neuronal-like cells (Fig. 6), suggesting that mHtt increases
Sp1 and Sp3 activity at the REST promoter in neurons. Several
studies reported that Sp1 proteins are moderately but significantly
increased (by about 2-fold) in the brain of HD mice and in striatal
or neuronal cells expressing mHtt [20,22,51]. Accordingly, overall
DNA binding by Sp1 was increased in R6/2 mouse brain nuclear
extracts [20]. We asked whether Sp1 or Sp3 increased activity in
NG108 neuronal-like cells expressing Nter-mHtt could be
explained by an increase in protein level, but we could not detect
a significant change of Sp1 or Sp3 level in these cells (data not
shown). This is likely due to the transfection efficiency, which did
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conditions, a moderate (2-fold) increase of Sp1 or Sp3 proteins
would be very difficult to quantify. A growing number of studies
have shown that the activities of Sp factors are regulated in signal-
and tissue-specific manners and play a critical role in the
regulation of inducible gene expression, thus controlling cell
homeostasis as well as major physiological processes, including
growth control, differentiation or survival. For instance, it has been
shown that oxidative stress induces Sp1 and Sp3 transcriptional
activities in cortical neurons [51]. Similarly, treatment of neurons
with excitotoxic drugs leading to oxidative stress, including the
mitochondrial toxin 3-NP or the glutamate receptor agonist kainic
acid, results in induction of Sp1/Sp3 activities [51,57]. In HD
mice and patients, oxidative stress, which is in part mediated by
excitotoxic mechanisms, has been shown to be increased [58],
suggesting that Sp1/Sp3 activation might be driven by oxidative
stress in HD. Interestingly, treatments inducing oxidative stress,
including kainic acid and ischemia, derepress REST expression in
various types of neurons [15,59,60]. It is therefore tempting to
speculate that the detrimental upregulation of REST in HD
neurons, which is expected to impair the identity of neurons,
involves Sp1 and Sp3 functions and may be oxidative stress-
mediated. This situation might be reminiscent to what we
observed previously in the context of a SCA7 retinal mouse
model, where alteration of the neuronal differentiation program by
mutant ataxin-7 appeared to be stress-induced [15,46,61].
In conclusion, our study together with earlier reports suggest
that mHtt fragments trigger a pathogenic cascade involving
activation of Sp1 and Sp3, which in turn upregulates REST that
represses neuronal genes in HD. Supporting this view, the
reduction of Sp1 function in HD mice and the reduction of
REST in HD cells have both proven to be beneficial [21,22,29].
Supporting Information
Figure S1 Alignment of the human, mouse and rat REST gene
promoters. The nucleotide sequences of the three exons a, b and c
and their respective upstream promoters are shown. Nucleotide
numbers on the right of each lane correspond to the human
promoter with respect to the ATG start codon. Conserved
nucleotides are marked with asterisk. Sequences in bold corre-
spond to three exons. The putative binding sites for AP-1
(underlined), NF-Kappa B (grey boxes) and Sp factors (GC-box
in black) are indicated.
Found at: doi:10.1371/journal.pone.0014311.s001 (17.10 MB
TIF)
Figure S2 Relative Sp1 and Sp3 protein levels in NG108 cells
during 12 days of neuronal differentiation. Sp1 and the long and
two short isoforms of Sp3 (L-Sp3 and S-Sp3, respectively) protein
levels were quantified on western blots shown in figure 6A and
normalized using beta-Tubulin as loading control. *P,0,05;
**P,0,01 and ***P,0,001.
Found at: doi:10.1371/journal.pone.0014311.s002 (0.14 MB TIF)
Figure S3 Effect of Sp1 and Sp3 knockdown on Sp1 and Sp3
expression levels in undifferentiated NG108 cells. NG108 cells
were transfected with specific Sp1 siRNA, Sp3 siRNA or control
siRNA and analyzed 48 h later for Sp1 and Sp3 mRNA levels by
quantitative RT-PCR (A) and protein levels by western blot (B).
Each bar represents the mean value 6 sem of at least 4
independent experiments performed in triplicate. *P,0,05, Sp1
siRNA or Sp3 siRNA transfected cells vs. control siRNA
transfected cells.
Found at: doi:10.1371/journal.pone.0014311.s003 (0.56 MB TIF)
Figure S4 A dominant-negative of Sp factors downregulated the
promoter of MLN64 gene. The pGL3-0.2-MLN64 vector, which
expresses the luciferase gene driven by the MLN64 promoter [51]
was cotransfected with an empty pEBGN vector (open bar) or with
dominant-negative Sp1-encoding vector (pEBGN-Sp1) (solid bar)
and beta-galactosidase expression vector into NG108 cells. Cells
were harvested 48 h later to measure luciferase and beta-
galactosidase activities. Luciferase activity was normalized to
beta-galactosidase and activity of MLN64 promoter without
transfection of pEBGN-Sp1 was set as 1. Data are the mean
values 6 sem of 3 independent experiments performed in
triplicate. ***P,0,001, pEBGN-Sp1 vs pEBGN transfected cells.
Found at: doi:10.1371/journal.pone.0014311.s004 (0.14 MB TIF)
Figure S5 Effect of Sp1 and Sp3 knockdown on Sp1 and Sp3
expression levels in NG108 cells differentiated into neurons.
NG108 cells were cotransfected with Nter-15Q or Nter-142Q
vectors and with Sp1 siRNA, Sp3 siRNA, Sp1/sp3 siRNAs or
control siRNA. Cells were differentiated into neuronal-like cells for
6 days prior to analysis. (A) Sp1 mRNA level (left panel) and Sp3
mRNA level (right panel) were analyzed by quantitative RT-PCR.
Each bar represents the mean values 6 sd of a single
representative experiment performed in triplicate. ***P,0,001,
neuronal cells transfected with control siRNA vs neuronal cells
transfected with Sp1 or Sp3 siRNAs. (B) Sp1 protein level were
analyzed by western blot using beta-Tubulin as loading control.
(C) Sp3 protein level was analyzed by western blot using beta-
Tubulin as loading control.
Found at: doi:10.1371/journal.pone.0014311.s005 (3.37 MB TIF)
Figure S6 Sp1 and Sp3 bind REST promoter in the brain of 12
week-old R6/2 mice. (A) mRNA level of REST in the whole brain
of 12-week-old wild-type (WT) (open bar) and R6/2 mice (solid
bar). mRNA level was determined by quantitative RT-PCR. Each
bar represents the mean value 6 sem, *P,0,05 (WT: n=4; R6/2:
n=4). (B) ChIP assay was performed to detect Sp1 and Sp3 on
REST promoter in 12 week-old R6/2 and wild-type (WT) brains
using anti-Sp1 and anti-Sp3 antibodies. Sequences covering the
regions A in mouse REST promoter corresponding to the region
A3 in human REST promoter was amplified. As a negative
control, a sequence 2.0 kb upstream of the region A (N) was
amplified. Results are expressed as fold enrichment compared to
value obtained after amplification of the regions treated with no
antibody. Each immunoprecipitation was performed in triplicate,
corresponding to 3 different mice. The bars represent the mean
value obtained from triplicate +/2 sem; * P,0,05.
Found at: doi:10.1371/journal.pone.0014311.s006 (0.16 MB TIF)
Table S1 Oligonucleotide primers used for DNA amplification
of human NRSF promoter regions.
Found at: doi:10.1371/journal.pone.0014311.s007 (0.05 MB
DOCX)
Table S2 Oligonucleotide primers used for direct mutagenesis of
the putative NF-KappaB binding sites of human NRSF promoter
regions named A, B and C.
Found at: doi:10.1371/journal.pone.0014311.s008 (0.05 MB
DOCX)
Table S3 Oligonucleotide primers used for gene expression
analysis by quantitative real-time reverse transcription-PCR.
Found at: doi:10.1371/journal.pone.0014311.s009 (0.04 MB
DOCX)
Table S4 Oligonucleotide primers used for chromatin immuno-
precipitation analysis of mouse NRSF promoter by quantitative
real-time reverse transcription-PCR.
Sp1 Activation of REST in HD
PLoS ONE | www.plosone.org 10 December 2010 | Volume 5 | Issue 12 | e14311Found at: doi:10.1371/journal.pone.0014311.s010 (0.05 MB
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